Guardian Capital Advisors LP Pfizer Inc Transaction History

Guardian Capital Advisors LP

$967 Million
Q3 2024

A detailed history of Guardian Capital Advisors LP transactions in Pfizer Inc stock. As of the latest transaction made, Guardian Capital Advisors LP holds 111,071 shares of PFE stock, worth $2.88 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

111,071

Previous 133,545 16.83%

Holding current value

$2.88 Million

Previous $3.74 Million 13.97%

% of portfolio

0.33%

Previous 0.43%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $622,529 - $705,458	-22,474 Reduced 16.83%	111,071 $3.21 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $294,986 - $345,668	-11,678 Reduced 8.04%	133,545 $3.74 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $1.18 Million - $1.35 Million	45,473 Added 45.59%	145,223 $4.03 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $217,767 - $282,855	-8,334 Reduced 7.71%	99,750 $2.87 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $80,064 - $93,587	-2,495 Reduced 2.26%	108,084 $3.59 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $40,923 - $47,348	-1,133 Reduced 1.01%	110,579 $4.06 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $383,461 - $499,210	-9,735 Reduced 8.02%	111,712 $4.56 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $160,528 - $209,552	3,845 Added 3.27%	121,447 $6.23 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.26 Million - $1.54 Million	-28,785 Reduced 19.66%	117,602 $4.94 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $247,958 - $294,000	-5,329 Reduced 3.51%	146,387 $7.52 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $14,274 - $17,687	-312 Reduced 0.21%	151,716 $8.06 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $41,485 - $61,495	1,004 Added 0.66%	152,028 $8.61 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $247,667 - $318,150	6,310 Added 4.36%	151,024 $6.41 Million
Q2 2021 Aug 17, 2021	BUY	$35.91 - $40.68 $228,387 - $258,724	6,360 Added 4.6%	144,714 $5.75 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $270,096 - $304,615	8,065 Added 6.19%	138,354 $5.14 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $257,852 - $327,882	7,704 Added 6.28%	130,289 $4.85 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $29,527 - $34,642	930 Added 0.76%	122,585 $4.52 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $302,254 - $366,678	10,035 Added 8.99%	121,655 $3.15 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $11,622 - $16,606	430 Added 0.39%	111,620 $2.49 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $21,562 - $24,470	-655 Reduced 0.59%	111,190 $4.46 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $50,684 - $65,722	-1,560 Reduced 1.38%	111,845 $3.88 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $70,446 - $79,095	-1,905 Reduced 1.65%	113,405 $5.04 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $49,875 - $54,796	1,330 Added 1.17%	115,310 $4.54 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $244,861 - $279,168	-6,365 Reduced 5.29%	113,980 $4.83 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $146,669 - $177,901	-4,255 Reduced 3.41%	120,345 $5.47 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $236,631 - $252,272	-7,175 Reduced 5.44%	124,600 $4.66 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $298,677 - $346,507	-9,360 Reduced 6.63%	131,775 $4.79 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $19,423 - $20,609	-584 Reduced 0.41%	141,135 $5.21 Million
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $13,764 - $15,162	444 Added 0.31%	141,719 $5.16 Million
Q2 2017 Aug 14, 2017	BUY	N/A	141,275	141,275 $4.7 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital Advisors LP with notifications on news.

Account

Guardian Capital Advisors LP Pfizer Inc Transaction History